nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Formation of a Medical Advisory Board
nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) and Veteran's Healthcare Supply Solutions (VHSS) Announces A National Distribution Agreement for the nanoMesh™ Product Line Offering to the Clinical Community
nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Expansion of the nanoMesh™ Product Line Offering to the Clinical Community
nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Secondary Endpoint Achieved in nanoMesh™ Pathogen Inhibiting Protein (PIP) Uptake Studies
nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Primary Endpoint Achieved in nanoMesh™ Pathogen Inhibiting Protein (PIP) Uptake Studies
nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces First-In-Man Clinical Implantation of nanoMesh™
nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Completion Filing of a Second Pre-Marketing Notification Application (510(k)) With The US Food and Drug Administration (FDA) nanoMesh™
Exogenesis Corporation to Highlight Accelerated Neutral Atom Beam (ANAB) Technology for Nanoscale Surface Processing during the TechConnect World 2019 Congress
Exogenesis Corporation Receives 510(k) Clearance for the Exogenesis Hernia Mesh, First Soft Tissue Repair Device with Nano-Modified Surface